youtube-channel-logo

  • Vietnamese (VN)
  • English (UK)
  1. Products search
  2. News search
  • Home
  • About Us
    • Our History
    • Our Values, Mission & Vision
    • Domestic Distribution
  • News
  • Activities
  • Products
    • Analgesic - Antipyretic
    • Respiratory
    • Nutrition
    • Musculoskeletal
    • Gastrointestinal – Hepatobiliary
    • Nervous – Ophthalmic
    • Cardiovascular – Diabetic
    • Dermatology – Beauty care
  • Overview
  • Export
  • Investor Relations
    • Announcement
      • 2022
      • 2021
      • 2020
      • 2019
      • 2018
      • 2017
      • Read more
        • 2016
        • 2015
        • 2014
        • 2013
    • Annual General Meeting (AGM)
      • 2022
      • 2021
      • 2020
      • 2019
      • 2018
      • 2017
      • Read more
        • 2016
        • 2015
        • 2014
        • 2013
        • Before 2012
    • Annual Report
    • Financial Statements
      • 2022
      • 2021
      • 2020
      • 2019
      • 2018
      • 2017
      • Read more
        • 2016
        • 2015
        • 2014
        • 2013
        • Before 2012
    • IR News
    • DHG Pharma’s Charter
    • Regulation on Corporate Governance
      • Report on corporate governance
        • 2021
        • 2020
        • 2019
        • 2018
        • 2017
        • Read more
          • 2015
      • Regulations on corporate governance
  • Contact

  • Home
  • Investor Relations
  • Financial Statements
  • 2020
  • Audited financial statements in 2020 and explanation of changes

Audited financial statements in 2020 and explanation of changes

Details
Published: 07 March 2021
Hits: 2155
fShare
Tweet
  • Audited consolidated financial statements of DHG Pharma 2020
  • Audited separate financial statements of DHG Pharma 2020
  • Explanation of changes

Older news items:

  • Financial Statements of DHG Pharma in 2020 - 20/01/2021 16:03
  • Financial statements in Q3/2020 - 20/10/2020 08:12
  • DHG Pharma Reviewed Financial Statements 1H2020 - 14/08/2020 03:34
  • Financial statements in Q2/2020 - 21/07/2020 02:12
  • Financial statements in Q1/2020 - 20/04/2020 10:27

Contact information

DHG Pharmaceutical Joint-Stock Company

Address: 288 Bis, Nguyen Van Cu Street, An Hoa Ward, Ninh Kieu District, Can Tho City

Representative: Mr Masashi Nakaura            

Contact: +84.292.3891433 – 3890802

Email: dhgpharma@dhgpharma.com.vn

Business registration certificate: No. 1800156801 issued by Can Tho City Department of Planning and Investment on January 2, 2020

License for setting up general information website No. 07A/GP-TTĐT issued by Can Tho City Department of Information and Communications on Sep 26, 2017

dhg dathongbao

Back to top